Low-dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.
作者信息
Iurlo Alessandra, Cattaneo Daniele, Malato Alessandra, Accurso Vincenzo, Annunziata Mario, Gozzini Antonella, Scortechini Anna Rita, Bucelli Cristina, Scalzulli Emilia, Attolico Imma, Maggi Alessandro, Martino Bruno, Caocci Giovanni, Abruzzese Elisabetta, Pregno Patrizia, Luciano Luigiana, Breccia Massimo
机构信息
Division of Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Division of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
出版信息
Am J Hematol. 2020 Oct;95(10):E260-E263. doi: 10.1002/ajh.25908. Epub 2020 Jul 7.
PMID:32557788
Abstract
摘要
Zotero 插件